Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

State-of-the-Art

Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials

Abstract

Maternal–child health benefits of optimizing vitamin D status during pregnancy may include a reduced risk of pre-eclampsia, improved fetal growth and beneficial effects on infant immune function. These hypotheses require evaluation by randomized controlled antenatal vitamin D supplementation trials using doses that are high enough to elevate serum 25-hydroxyvitamin D concentrations into the range believed to be associated with improved health outcomes. Such doses may be considerably higher than the current recommended dietary allowance (600 IU day–1) or standard prenatal supplement dose (400 IU day–1), and may even be higher than the tolerable upper intake level (4000 IU day–1) advised by the Institute of Medicine (2010). A critical review of the published literature yielded limited data regarding the safety of antenatal vitamin D regimens. There have been no published reports of the teratogenic effects of vitamin D on humans. Some animal studies have suggested the potential for dose-dependent fetal toxicities (for example, growth impairment, skeletal malformations and cardiovascular anomalies), but the relevance of these observations to humans is unknown. Antenatal vitamin D supplementation trials should incorporate a range of methods for objectively establishing maternal and fetal safety, and aim to identify the lowest doses of vitamin D required to achieve target outcomes.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bodnar LM, Simhan HN . Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv 2010; 65 (4): 273–284.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Pasco JA, Wark JD, Carlin JB, Ponsonby AL, Vuillermin PJ, Morley R . Maternal vitamin D in pregnancy may influence not only offspring bone mass but other aspects of musculoskeletal health and adiposity. Med Hypotheses 2008; 71 (2): 266–269.

    Article  CAS  PubMed  Google Scholar 

  3. Hollis BW . Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 2007; 22 (Suppl 2): V39–V44.

    Article  CAS  PubMed  Google Scholar 

  4. Litonjua AA, Weiss ST . Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007; 120 (5): 1031–1035.

    Article  CAS  PubMed  Google Scholar 

  5. Williams AF . Vitamin D in pregnancy: an old problem still to be solved? Arch Dis Child 2007; 92 (9): 740–741.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mahomed K, Gulmezoglu AM . Vitamin D supplementation in pregnancy. Cochrane Database Syst Rev 2000; (2): CD000228.

  7. Ross AC, Taylor CL, Yaktine AL, Del Valle HB . Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press: Washington, 2010.

    Google Scholar 

  8. Seamans KM, Cashman KD . Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009; 89 (6): 1997S–12008.

    Article  CAS  PubMed  Google Scholar 

  9. Vieth R, Chan PC, MacFarlane GD . Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73 (2): 288–294.

    Article  CAS  PubMed  Google Scholar 

  10. Bischoff-Ferrari H, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett W . Benefit–risk assessment of vitamin D supplementation. Osteoporos Int 2009; 21 (7): 1121–1132.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Vieth R . What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006; 92 (1): 26–32.

    Article  CAS  PubMed  Google Scholar 

  12. Hollis BW . Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135 (2): 317–322.

    Article  CAS  PubMed  Google Scholar 

  13. Masterjohn C . Vitamin D toxicity redefined: vitamin K and the molecular mechanism. Med Hypotheses 2007; 68 (5): 1026–1034.

    Article  CAS  PubMed  Google Scholar 

  14. Vieth R . Vitamin D toxicity, policy, and science. J Bone Miner Res 2007; 22 (Suppl 2): V64–V68.

    Article  CAS  PubMed  Google Scholar 

  15. Schnatz PF, Curry SL . Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002; 57 (6): 365–376.

    Article  PubMed  Google Scholar 

  16. Clements MR, Fraser DR . Vitamin D supply to the rat fetus and neonate. J Clin Invest 1988; 81 (6): 1768–1773.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rebut-Bonneton C, Demignon J, Cancela L, Miravet L . Effect of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 maternal loads on maternal and fetal vitamin D metabolite levels in the rat. Reprod Nutr Dev 1985; 25 (3): 583–590.

    Article  CAS  PubMed  Google Scholar 

  18. Kovacs CS, Kronenberg HM . Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997; 18 (6): 832–872.

    CAS  PubMed  Google Scholar 

  19. Bond H, Dilworth MR, Baker B, Cowley E, Requena Jimenez A, Boyd RD et al. Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice. J Physiol 2008; 586 (7): 2015–2025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Simmonds CS, Karsenty G, Karaplis AC, Kovacs CS . Parathyroid hormone regulates fetal-placental mineral homeostasis. J Bone Miner Res 2010; 25 (3): 594–605.

    Article  CAS  PubMed  Google Scholar 

  21. Kovacs CS, Woodland ML, Fudge NJ, Friel JK . The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am J Physiol Endocrinol Metab 2005; 289 (1): E133–E144.

    Article  CAS  PubMed  Google Scholar 

  22. Durand D, Braithwaite GD, Barlet JP . The effect of 1 alpha-hydroxycholecalciferol on the placental transfer of calcium and phosphate in sheep. Br J Nutr 1983; 49 (3): 475–480.

    Article  CAS  PubMed  Google Scholar 

  23. Kubota M, Ohno J, Shiina Y, Suda T . Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3. Endocrinology 1982; 110 (6): 1950–1956.

    Article  CAS  PubMed  Google Scholar 

  24. Hollis BW, Pittard III WB . Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab 1984; 59 (4): 652–657.

    Article  CAS  PubMed  Google Scholar 

  25. Marx SJ, Swart Jr EG, Hamstra AJ, DeLuca HF . Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1980; 51 (5): 1138–1142.

    Article  CAS  PubMed  Google Scholar 

  26. Wieland P, Fischer JA, Trechsel U, Roth HR, Vetter K, Schneider H et al. Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol Endocrinol Metab 1980; 239 (5): E385–E390.

    Article  CAS  Google Scholar 

  27. Fleischman AR, Rosen JF, Cole J, Smith CM, Deluca HF . Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr 1980; 97 (4): 640–642.

    Article  CAS  PubMed  Google Scholar 

  28. Markestad T, Aksnes L, Ulstein M, Aarskog D . 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. Am J Clin Nutr 1984; 40 (5): 1057–1063.

    Article  CAS  PubMed  Google Scholar 

  29. Brooke OG, Brown IR, Bone CD, Carter ND, Cleeve HJ, Maxwell JD et al. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 1980; 280 (6216): 751–754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zeghoud F, Garabedian M, Jardel A, Bernard N, Melchior J . [Administration of a single dose of 100,000 U.I. of vitamin D3 in the pregnant woman in winter. The effect on blood calcium level of the newborn infant]. J Gynecol Obstet Biol Reprod (Paris) 1988; 17 (8): 1099–1105.

    CAS  Google Scholar 

  31. Marya RK, Rathee S, Dua V, Sangwan K . Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res 1988; 88: 488–492.

    CAS  PubMed  Google Scholar 

  32. Congdon P, Horsman A, Kirby PA, Dibble J, Bashir T . Mineral content of the forearms of babies born to Asian and white mothers. Br Med J (Clin Res Ed) 1983; 286 (6373): 1233–1235.

    Article  CAS  Google Scholar 

  33. Marya RK, Rathee S, Lata V, Mudgil S . Effects of vitamin D supplementation in pregnancy. Gynecol Obstet Invest 1981; 12 (3): 155–161.

    Article  CAS  PubMed  Google Scholar 

  34. Delvin EE, Salle BL, Glorieux FH, Adeleine P, David LS . Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr 1986; 109 (2): 328–334.

    Article  CAS  PubMed  Google Scholar 

  35. Cockburn F, Belton NR, Purvis RJ, Giles MM, Brown JK, Turner TL et al. Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J 1980; 281 (6232): 11–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Madelenat P, Bastian H, Menn S . Winter supplementation in the 3rd trimester of pregnancy by a dose of 80,000 IU of vitamin D]. J Gynecol Obstet Biol Reprod (Paris) 2001; 30 (8): 761–767.

    CAS  Google Scholar 

  37. Greer FR, Hollis BW, Napoli JL . High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2. J Pediatr 1984; 105 (1): 61–64.

    Article  CAS  PubMed  Google Scholar 

  38. Wright AD, Joplin GF, Dixon HG . Post-partum hypercalcaemia in treated hypoparathyroidism. Br Med J 1969; 1 (5635): 23–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Payne RB, Little AJ, Evans RT . Albumin-adjusted calcium concentration in serum increases during normal pregnancy. Clin Chem 1990; 36 (1): 142–144.

    CAS  PubMed  Google Scholar 

  40. Larsson A, Palm M, Hansson LO, Axelsson O . Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008; 115 (7): 874–881.

    Article  CAS  PubMed  Google Scholar 

  41. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW . 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008; 87 (6): 1738–1742.

    Article  CAS  PubMed  Google Scholar 

  42. Vieth R, McCarten K, Norwich KH . Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production. Am J Physiol 1990; 258 (5 Pt 1): E780–E789.

    CAS  PubMed  Google Scholar 

  43. Vieth R, Milojevic S, Peltekova V . Improved cholecalciferol nutrition in rats is noncalcemic, suppresses parathyroid hormone and increases responsiveness to 1, 25-dihydroxycholecalciferol. J Nutr 2000; 130 (3): 578–584.

    Article  CAS  PubMed  Google Scholar 

  44. Stern PH, Taylor AB, Bell NH, Epstein S . Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest 1981; 68 (5): 1374–1377.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R . Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008; 93 (9): 3430–3435.

    Article  CAS  PubMed  Google Scholar 

  46. Ilahi M, Armas LA, Heaney RP . Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008; 87 (3): 688–691.

    Article  CAS  PubMed  Google Scholar 

  47. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008; 93 (8): 3015–3020.

    Article  CAS  PubMed  Google Scholar 

  48. Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V et al. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010; 95 (10): 4771–4777.

    Article  CAS  PubMed  Google Scholar 

  49. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR . High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009; 20 (8): 1407–1415.

    Article  CAS  PubMed  Google Scholar 

  50. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303 (18): 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  51. Leventis P, Kiely PD . The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009; 38 (2): 149–153.

    Article  CAS  PubMed  Google Scholar 

  52. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP . Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995; 122 (7): 511–513.

    Article  CAS  PubMed  Google Scholar 

  53. Jones G . Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88 (2): 582S–586S.

    Article  CAS  PubMed  Google Scholar 

  54. Shephard RM, Deluca HF . Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. Arch Biochem Biophys 1980; 202 (1): 43–53.

    Article  CAS  PubMed  Google Scholar 

  55. Vieth R . Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of ‘free’ 1,25-dihydroxyvitamin D. Clin Chem 1994; 40 (3): 435–441.

    CAS  PubMed  Google Scholar 

  56. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M . Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005; 97 (1–2): 103–109.

    Article  CAS  PubMed  Google Scholar 

  57. Stern PH, De Olazabal J, Bell NH . Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest 1980; 66 (4): 852–855.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 2002; 161 (1): 105–114.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009; 284 (22): 14838–14848.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Avila E, Diaz L, Barrera D, Halhali A, Mendez I, Gonzalez L et al. Regulation of vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts. J Steroid Biochem Mol Biol 2007; 103 (1): 90–96.

    Article  CAS  PubMed  Google Scholar 

  61. Vigano P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006; 36 (3): 415–424.

    Article  CAS  PubMed  Google Scholar 

  62. Turner M, Barre PE, Benjamin A, Goltzman D, Gascon-Barre M . Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy? Miner Electrolyte Metab 1988; 14 (4): 246–252.

    CAS  PubMed  Google Scholar 

  63. Verhaeghe J, Bouillon R . Calciotropic hormones during reproduction. J Steroid Biochem Mol Biol 1992; 41 (3-8): 469–477.

    Article  CAS  PubMed  Google Scholar 

  64. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW . Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008; 149 (7): 3656–3667.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Bikle DD, Gee E, Halloran B, Haddad JG . Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74 (6): 1966–1971.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. van Hoof HJ, de Sevaux RG, van Baelen H, Swinkels LM, Klipping C, Ross HA et al. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur J Endocrinol 2001; 144 (4): 391–396.

    Article  CAS  PubMed  Google Scholar 

  67. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P . Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 1981; 67 (3): 589–596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Mallet E, Gugi B, Brunelle P, Henocq A, Basuyau JP, Lemeur H . Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gynecol 1986; 68 (3): 300–304.

    Article  CAS  PubMed  Google Scholar 

  69. Armas LA, Hollis BW, Heaney RP . Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89 (11): 5387–5391.

    Article  CAS  PubMed  Google Scholar 

  70. Hollis BW, Wagner CL . Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004; 80 (6 Suppl): 1752S–1758S.

    Article  CAS  PubMed  Google Scholar 

  71. Coe FL, Parks JH, Lindheimer MD . Nephrolithiasis during pregnancy. N Engl J Med 1978; 298 (6): 324–326.

    Article  CAS  PubMed  Google Scholar 

  72. Resim S, Ekerbicer HC, Kiran G, Kilinc M . Are changes in urinary parameters during pregnancy clinically significant? Urol Res 2006; 34 (4): 244–248.

    Article  PubMed  Google Scholar 

  73. Hathcock JN, Shao A, Vieth R, Heaney R . Risk assessment for vitamin D. Am J Clin Nutr 2007; 85 (1): 6–18.

    Article  CAS  PubMed  Google Scholar 

  74. van den Berg H . Bioavailability of vitamin D. Eur J Clin Nutr 1997; 51 (Suppl 1): S76–S79.

    PubMed  Google Scholar 

  75. Lawson DE, Sedrani SH, Douglas J . Interrelationships in rats of tissue pools of cholecalciferol and 25-hydroxycholecalciferol formed in u.v. light. Biochem J 1986; 233 (2): 535–540.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Avioli LV, Lee SW, McDonald JE, Lund J, DeLuca HF . Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest 1967; 46 (6): 983–992.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Stamp TC, Haddad JG, Twigg CA . Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1977; 1 (8026): 1341–1343.

    Article  CAS  PubMed  Google Scholar 

  78. Brouwer DA, van Beek J, Ferwerda H, Brugman AM, van der Klis FR, van der Heiden HJ et al. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr 1998; 79 (6): 527–532.

    Article  CAS  PubMed  Google Scholar 

  79. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J . Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91 (6): 2552–2555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Fraser DR . The physiological economy of vitamin D. Lancet 1983; 1 (8331): 969–972.

    Article  CAS  PubMed  Google Scholar 

  81. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF . Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998; 8 (3): 222–230.

    Article  CAS  PubMed  Google Scholar 

  82. Vieth R . The pharmacology of vitamin D, including fortification strategies. In: Feldman D, Glorieux F, Pike JW (eds). Vitamin D, 2nd edn. Elsevier: New York, 2005, pp 995–1015.

    Chapter  Google Scholar 

  83. Clements MR, Chalmers TM, Fraser DR . Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis. Lancet 1984; 1 (8391): 1376–1379.

    Article  CAS  PubMed  Google Scholar 

  84. Holick MF, Garabedian M, Schnoes HK, DeLuca HF . Relationship of 25-hydroxyvitamin D3 side chain structure to biological activity. J Biol Chem 1975; 250 (1): 226–230.

    CAS  PubMed  Google Scholar 

  85. Tuckey RC, Li W, Zjawiony JK, Zmijewski MA, Nguyen MN, Sweatman T et al. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J 2008; 275 (10): 2585–2596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Zbytek B, Janjetovic Z, Tuckey RC, Zmijewski MA, Sweatman TW, Jones E et al. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 2008; 128 (9): 2271–2280.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 2004; 271 (21): 4178–4188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Chen TC, Persons KS, Lu Z, Mathieu JS, Holick MF . An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3 and previtamin D3. J Nutr Biochem 2000; 11 (5): 267–272.

    Article  CAS  PubMed  Google Scholar 

  89. Harcourt-Brown F . Textbook of Rabbit Medicine. Elsevier: Philadelphia, 2002.

    Google Scholar 

  90. Norman P, Moss I, Sian M, Gosling M, Powell J . Maternal and postnatal vitamin D ingestion influences rat aortic structure, function and elastin content. Cardiovasc Res 2002; 55 (2): 369–374.

    Article  CAS  PubMed  Google Scholar 

  91. Tukaj C . Enhanced proliferation of aortal smooth muscle cells treated by 1,25(OH)2D3 in vitro coincides with impaired formation of elastic fibres. Int J Exp Pathol 2008; 89 (2): 117–124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Vieth R . Vitamin D ingestion and changes to rat aorta. Cardiovasc Res 2002; 56 (2): 323–324; author reply 325.

    Article  CAS  PubMed  Google Scholar 

  93. Toda T, Toda Y, Kummerow FA . Coronary arterial lesions in piglets from sows fed moderate excesses of vitamin D. Tohoku J Exp Med 1985; 145 (3): 303–310.

    Article  CAS  PubMed  Google Scholar 

  94. Gezmish O, Tare M, Parkington HC, Morley R, Porrello ER, Bubb KJ et al. Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci 2009; 17 (2): 168–176.

    Article  PubMed  CAS  Google Scholar 

  95. Ewart AK, Morris CA, Atkinson D, Jin W, Sternes K, Spallone P et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet 1993; 5 (1): 11–16.

    Article  CAS  PubMed  Google Scholar 

  96. Forbes GB, Cafarelli C, Manning J . Vitamin D and infantile hypercalcemia. Pediatrics 1968; 42 (1): 203–204.

    CAS  PubMed  Google Scholar 

  97. Callies F, Arlt W, Scholz HJ, Reincke M, Allolio B . Management of hypoparathyroidism during pregnancy--report of twelve cases. Eur J Endocrinol 1998; 139 (3): 284–289.

    Article  CAS  PubMed  Google Scholar 

  98. Anderson GW, Musselman L . The treatment of tetany in pregnancy. Am J Obstet Gynecol 1942; 43: 547–567.

    Article  Google Scholar 

  99. Stander HJ, Ahearn RE . The parathyroids in pregnancy. J Mt Sinai Hosp NY 1947; 14 (3): 629–633.

    CAS  Google Scholar 

  100. Antia AU, Wiltse HE, Rowe RD, Pitt EL, Levin S, Ottesen OE et al. Pathogenesis of the supravalvular aortic stenosis syndrome. J Pediatr 1967; 71 (3): 431–441.

    Article  CAS  PubMed  Google Scholar 

  101. Forfar JO, Balf CL, Maxwell GM, Tompsett SL . Idiopathic hypercalcaemia of infancy; clinical and metabolic studies with special reference to the aetiological role of vitamin D. Lancet 1956; 270 (6930): 981–988.

    Article  CAS  PubMed  Google Scholar 

  102. McCue CM, Spicuzza TJ, Robertson LW, Mauck Jr HP . Familial supravalvular aortic stenosis. J Pediatr 1968; 73 (6): 889–895.

    Article  CAS  PubMed  Google Scholar 

  103. Garcia RE, Friedman WF, Kaback MM, Rowe RD . Idiopathic hypercalcemia and supravalvular aortic stenosis. Documentation of a new syndrome. N Engl J Med 1964; 271: 117–120.

    Article  CAS  PubMed  Google Scholar 

  104. Houghton LA, Vieth R . The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006; 84 (4): 694–697.

    Article  CAS  PubMed  Google Scholar 

  105. Brehm W . Potential dangers of viosterol during pregnancy with observations of calcification of placentae. Ohio State Med J 1937; 33 (9): 989–993.

    Google Scholar 

  106. Gertner JM, Coustan DR, Kliger AS, Mallette LE, Ravin N, Broadus AE . Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med 1986; 81 (3): 451–456.

    Article  CAS  PubMed  Google Scholar 

  107. Roelofsen JM, Berkel GM, Uttendorfsky OT, Slegers JF . Urinary excretion rates of calcium and magnesium in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 1988; 27 (3): 227–236.

    Article  CAS  PubMed  Google Scholar 

  108. Wagner CL, Johnson D, Hulsey TC, Ebeling M, Shary J, Smith PG et al. Vitamin D supplementation during pregnancy Part I NICHD/CTSA randomized clinical trial (RCT): safety considerations. E-PAS 2010: 2630.7. Available at http://www.pas-meeting.org/2011Denver/abstract_archives.asp.

  109. Hayes DP . Adverse effects of nutritional inadequacy and excess: a hormetic model. Am J Clin Nutr 2008; 88 (2): 578S–581S.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

DER was supported by training grants from the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research during the preparation of this article. Parul Christian (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) is acknowledged for her helpful review of an earlier draft of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D E Roth.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Perinatology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roth, D. Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials. J Perinatol 31, 449–459 (2011). https://doi.org/10.1038/jp.2010.203

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.203

Keywords

This article is cited by

Search

Quick links